AZD2927

a potassium channel blocking agent with antiarrhythmic activity; structure in first source

Also Known As:

4-fluoro-N-(1-(3-hydroxyazetidin-1-yl)-3-methylbutan-2-yl)-N,3-dimethylbenzamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Anfinsen, Ole-Gunnar: 1 article (03/2015)
2.	Berggren, Anders: 1 article (03/2015)
3.	Carlsson, Leif: 1 article (03/2015)
4.	Frison, Lars: 1 article (03/2015)
5.	Jensen, Steen: 1 article (03/2015)
6.	Linhardt, Gunilla: 1 article (03/2015)
7.	Nordkam, Ann-Christin: 1 article (03/2015)
8.	Sundqvist, Monika: 1 article (03/2015)
9.	Walfridsson, Håkan: 1 article (03/2015)

1.	Atrial Flutter (Flutter, Atrial) 03/01/2015 - "In atrial flutter patients (n = 18) undergoing an invasive investigation, AZD2927 did not change LAERP, the paced QT interval, or ventricular refractoriness when compared with placebo. "